KOZMARLO — 2466158

Toolbar

Details

Application number

2466158

Type(s)

Standard Characters

Category

Trademark

CIPO Status

FORMALIZED

TM5 status

LIVE/APPLICATION/ Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Filed

2026-04-01

Applicant

Juno Therapeutics, Inc.
400 Dexter Avenue North, Suite 1200
Seattle, WA 98109
UNITED STATES OF AMERICA

Agent

GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5

Documents

Index headings

  • KOZMARLO

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.

Claims

  • Priority Filing Date: February 12, 2026, Country or Office: UNITED STATES OF AMERICA, Application No. 99649965 in association with the same kind of goods

Action History

Actions
Action Action date Due date Comments
Filed 2026-04-01
Created 2026-04-01
Formalized 2026-04-01
Pre-Assessment Letter Sent 2026-04-16 Retired Goods or Services
Date modified: